Research Article

Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke

Table 1

Clinical characteristics of groups I and II.

Clinical featureGroup I ()Group II ()

Qualitative parameters (%) (%) value
Male gender20 (46.5)10 (45.5)0.9227
Sever clinical status
 NIH ≤ 7 (%)17 (39.6)
 NIH 8–1713 (30.2)
 NIH > 1813 (30.2)
Neurological status improvement
 No improvement16 (37.2)
 Improvement < 50%13 (30.2)
 Improvement > 50% or complete recovery14 (32.6)
 Death3 (7.0)
Hypertension43 (100)20 (90.9)0.2100
Dyslipidemia17 (39.6)7 (31.8)0.5419
Diabetes mellitus15 (34.9)6 (27.2)0.5347
Current smoking8 (18.6)4 (18.2)0.9328
Excessive alcohol intake8 (18.6)3 (13.6)0.5858
Obesity11 (25.6)4 (18.2)0.5029
Overweight20 (46.5)7 (31.8)0.2553
Coronary artery disease23 (53.5)7 (31.8)0.0973
Atrial fibrillation16 (37.2)6 (27.2)0.4231
ACE inhibitors33 (76.7)13 (59.1)0.1387
Aspirin18 (41.9)8 (36.4)0.1387
Enoxaparin2 (4.7)1 (4.5)0.9847
Quantitative parametersMean ± SDMean ± SD value
Age (y)75.2 ± 11.372.6 ± 9.30.1553
Plasma hsCRP (mg/L)8.2 ± 18.33.0 ± 7.60.0322
Plasma fibrinogen (mg/dL)378.3 ± 91.5360 ± 67.60.2517
White blood cells (WBC) (G/L)9.5 ± 3.216.6 ± 2.010.5723
Plasma total homocysteine (μmol/L)14.2 ± 8.812.0 ± 6.10.4969
Lipid profile (mg/dl)
 Total cholesterol178.2 ± 44.2176.1 ± 41.10.9117
 LDL cholesterol111.0 ± 39.4101 ± 31.20.3494
 HDL cholesterol45.5 ± 13.739 ± 11.20.1344
 Triglycerides113.3 ± 40.299 ± 30.20.3050

Chi-squared test. Mann–Whitney U test.